Chang Jin Wang
Founder at FRONTIER BIOTECHNOLOGIES INC.
Net worth: 19 M $ as of 2024-04-29
Profile
Chang Jin Wang is the founder of Frontier Biotechnologies, Inc. (China) since 2013, where he holds the title of General Manager & Director.
He previously held the position of Vice President-Business Development at VIVUS, Inc., Abmaxis, Inc., and TaiGen Biotechnology Co., Ltd.
from 2002 to 2006.
Dr. Wang holds a doctorate degree from the University of Kentucky and undergraduate and graduate degrees from West China University of Medical Sciences.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2022-09-29 | 21,059,500 ( 12.47% ) | 19 M $ | 2024-04-29 |
Chang Jin Wang active positions
Companies | Position | Start |
---|---|---|
FRONTIER BIOTECHNOLOGIES INC. | Founder | 2013-01-14 |
Former positions of Chang Jin Wang
Companies | Position | End |
---|---|---|
Abmaxis, Inc.
Abmaxis, Inc. Pharmaceuticals: MajorHealth Technology Abmaxis Inc. develops pharmaceutical drugs. The company discovers and optimizes monoclonal antibody (mAb) products for human therapeutics and diagnostics. It has developed antibody engineering technology platform, Abmaxis in-silico Immunization (AISIM TM), which they are used for building an internal product pipeline and collaboration with global biotech and pharmaceutical partners. The company was founded in 2000 and is located in Santa Clara, CA. | Corporate Officer/Principal | 2006-06-30 |
TaiGen Biotechnology Co., Ltd.
TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Corporate Officer/Principal | 2004-04-30 |
VIVUS, INC. | Corporate Officer/Principal | - |
Training of Chang Jin Wang
University of Kentucky | Doctorate Degree |
West China University of Medical Sciences | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
FRONTIER BIOTECHNOLOGIES INC. | Health Technology |
Private companies | 3 |
---|---|
VIVUS, Inc.
VIVUS, Inc. Pharmaceuticals: MajorHealth Technology VIVUS, Inc. engaged in the development and commercialization of novel therapeutic products. The firm’s products were indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and it was headquartered in Campbell, CA. | Health Technology |
Abmaxis, Inc.
Abmaxis, Inc. Pharmaceuticals: MajorHealth Technology Abmaxis Inc. develops pharmaceutical drugs. The company discovers and optimizes monoclonal antibody (mAb) products for human therapeutics and diagnostics. It has developed antibody engineering technology platform, Abmaxis in-silico Immunization (AISIM TM), which they are used for building an internal product pipeline and collaboration with global biotech and pharmaceutical partners. The company was founded in 2000 and is located in Santa Clara, CA. | Health Technology |
TaiGen Biotechnology Co., Ltd.
TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Health Technology |
- Stock Market
- Insiders
- Chang Jin Wang